Preparations of human albumin. Characteristics and therapeutic indications
Radović, M.; Pantelić, D.
Vojnosanitetski Pregled 36(1): 30-36
1979
ISSN/ISBN: 0042-8450 PMID: 462838 Document Number: 151814
Document emailed within 1 workday
Related Documents
2000: Indications for the use of human albumin solutions: an expert report. Human albumin expert group Schweizerische Medizinische Wochenschrift 130(14): 516-522Kosenkova, I.A.; Shatskaia, T.L.; Gavriuchenkova, L.P. 1995: Analysis of the composition of therapeutic preparations of immunoglobulin and albumin using chromatography on biochrome H-70 Gematologiia i transfuziologiia 40(5): 39-41
Kranz, T.; Schmidt, K.H. 1980: Gel chromatography for control purposes of human albumin preparations Developments in Biological Standardization 48: 93-103
Lundsgaard-Hansen, P.; Pappova, E.; Frei, E. 1980: Clinical indications for human serum albumin Developments in Biological Standardization 48: 69-74
Bulík, J. 1973: Depyrogenization technics in the production of preparations based on human albumin Ceskoslovenska Farmacie 22(5): 227-230
Myszkowska, K. 1971: Fractionation of some preparations of human blood albumin by means of molecular filtration Acta Poloniae Pharmaceutica 28(2): 213-218
Carsin, H. 1997: Human albumin solutions in the treatment of burned patients. Current indications Presse Medicale 26(10): 474-476
Komárek, P.; Chalabala, M.; Vavrejn, B. 1979: Albumin suspensions labelled with generator radionuclides technetium-99m and indium-113m. I. Technology and quality characteristics of a non-radioactive albumin suspension Ceskoslovenska Farmacie 28(8): 331-335
Azhyts'kyĭ, H.I.; Bélianova, L.I.; Malyĭ, K.D. 1975: Study of the amino acid composition of albumin fractions obtained from human serum albumin Ukrains'kyi Biokhimichnyi Zhurnal 47(1): 94-100
Nechay, B.R.; Saunders, J.P. 1978: Inhibitory characteristics of cadmium, lead, and mercury in human sodium and potassium dependent adenosinetriphosphatase preparations Journal of Environmental Pathology and Toxicology 2(2): 283-290
Steurer, J. 1999: Are there still indications for albumin? Wiener Klinische Wochenschrift 111(11): 450
Boros, B.; Péterfy, F.; Tóth, I. 1974: Impurities in gammaglobulin and albumin preparations: influence of the source material Developments in Biological Standardization 27: 102-106
Smorenburg, C.H.; ter Wee, P.M.; Gans, R.O. 1997: Clinical application of albumin: a closer look at indications Nederlands Tijdschrift Voor Geneeskunde 141(15): 719-723
Reznikov, I.P.; Semavin, I.E.; Bogomolov, B.P. 1986: Effect of preparations of placental albumin on serum alpha-fetoprotein levels Terapevticheskii Arkhiv 58(2): 102-104
Sigalov, A.B.; Isaeva, N.V.; Bezruchkina, S.V. 1993: The use of different albumin preparations as calibrators in determining the total protein in blood serum by the biuret method Klinicheskaia Laboratornaia Diagnostika (5): 56-58
Jungers, P.; Robino, C.; Choukroun, G.; Man, N.K. 2001: Indications and preparations for kidney dialysis La Revue du Praticien 51(4): 391-395
Lundholm, K. 1977: Albumin--various viewpoints on its therapeutic use Lakartidningen 74(32): 2694-2698
Radović, M.; Pantelić, D.; Taseski, J.; Milenković, L. 1979: Albumin and its therapeutic use - part i Bilten Za Hematologiju i Transfuziju 7(2-3): 137-144
Hansen, J.F.; Ezban, M. 1980: A new high quality albumin for therapeutic use Developments in Biological Standardization 48: 105-112
Avdeeva, Z.I.; Mazina, N.M.; Vakhromeeva, N.S.; Krylov, O.P.; Moskalenko, M.B.; Medunitsyn, N.V. 1990: The immunomodulating action of interferon preparations. 3. Changes in the phagocytic activity of human blood neutrophilic granulocytes under the influence of interferon preparations Vestnik Dermatologii i Venerologii 8: 23-28